11-12 September 2018 //  Lancaster Royal Hotel, London


Richard Janeczko

Dr Richard Janeczko

Chief Executive Officer, VEL Biosciences

Dr. Janeczko is one of the founding members of VB Biosciences. In his 25 years of experience in biotechnology and clinical sciences he has held senior executive roles in strategic marketing, business development as well as the office of CSO and CEO. In 2013 he formed DxEconomix Inc. to provide unique marketing services based on system-wide economic impact of medical devices and value-based pricing. Dr. Janeczko has extensive experience in clinical sciences, sequencing assays, proteomics, companion diagnostics, and personalized medicine. He has raised capital for start-up companies, brokered many deals and transactions for technologies and companies. Dr. Janeczko served as VP Emerging Markets and Technology at Luminex Corporation, as EVP Business Development and CSO at Tm Bioscience Inc., and as CEO of General Synthesis and Diagnostics. He holds a PhD in Biochemistry from the University of Alberta, a BSc in Food Microbiology from Strathclyde University, and is a member of several professional organizations and institutions.


2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad